Joint Juice Glucosamine Supplement Settlement
Premier Nutrition Corporation has agreed to a massive $90 million class action settlement to resolve claims that Joint Juice glucosamine drinks were falsely and deceptively advertised as providing joint health benefits. If you purchased Joint Juice in eligible states between 2009 and 2022, you may receive $10 to $50 per unit — no proof of purchase required for up to 6 units. File your claim by May 15, 2026.
What Is This Case About?
Two related class action lawsuits allege that Premier Nutrition Corporation falsely and deceptively marketed Joint Juice glucosamine supplement drinks as providing joint health benefits. The settlements cover purchases made in multiple states over periods generally between March 2009 and December 2022.
Who Is Eligible?
- Multi-State settlement: Purchasers of Joint Juice in California, Connecticut, Florida, Illinois, Maryland, Massachusetts, Michigan, or Pennsylvania during specified periods between March 1, 2009 and December 31, 2022
- New York settlement: Purchasers of Joint Juice in New York between December 5, 2013 and December 28, 2021
How Much Can You Receive?
- Multi-State: approximately $10 to $25 per unit depending on product type
- New York: approximately $50 per unit
- No proof of purchase required for up to 6 units
- Documentation required (receipts, order confirmations) for more than 6 units
How to File Before the Deadline
Submit your claim through the official Joint Juice Settlement website. New York residents should use the New York settlement page. You can also call 1-888-921-0720 for a paper claim form.
View this settlement on OpenClassActions.com for additional details and updates.
- Claim Deadline: May 15, 2026
- Settlement Amount: $90 million total ($70.8M multi-state + $19.2M New York)
- Case Type: False advertising — dietary supplement
OpenClassActions.org is not affiliated with Premier Nutrition Corporation or the settlement administrator. This page is for informational purposes only and does not constitute legal advice.
